Wize Pharma

Wize Pharma Net Debt/Equity

Delisted·Jan 10, 2019

The Net Debt to Equity Ratio of Wize Pharma (WIZP) as of Nov 19, 2026 is 12.43. In the previous year, Net Debt to Equity Ratio was -1.03 — a change of -1,301.80% (higher).

Net Debt/Equity

12.43

YoY

-1,301.80%

Last updated:

Net Debt to Equity Ratio of Wize Pharma is 2018 12.43 . Net Debt to Equity Ratio of Wize Pharma was 2017 -1.03 . It decreases by -1,301.80% higher compared to the previous year.

The Wize Pharma Net Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/Equity
Date
Net Debt/Equity
Jan 1, 2015
0.79 USD
Jan 1, 2016
-0.10 USD
Jan 1, 2017
-1.03 USD
Jan 1, 2018
12.43 USD
The Wize Pharma Net Debt/Equity history
YEARNet Debt/EquityYoY
12.43-1,301.80%
-1.03+959.69%
-0.10-112.31%
0.79—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

Net Debt to Equity Ratio of Wize Pharma is 12.43 in 2018.

Net Debt to Equity Ratio of Wize Pharma changed from -1.03 to 12.43, representing a -1,301.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Equity Ratio Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

Net Debt/Equity adjusts the debt-to-equity ratio by subtracting cash from total debt. It provides a more accurate picture of actual leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Equity Ratio's Wize Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Wize Pharma

All Key Metrics — Wize Pharma